Freedom Broker Cuts Oracle (NYSE:ORCL) Price Target to $205.00

Oracle (NYSE:ORCLFree Report) had its price target decreased by Freedom Broker from $210.00 to $205.00 in a research report report published on Monday,Benzinga reports. Freedom Broker currently has a buy rating on the enterprise software provider’s stock.

ORCL has been the topic of a number of other research reports. Bank of America raised their target price on shares of Oracle from $200.00 to $240.00 and gave the stock a “buy” rating in a research note on Tuesday, June 9th. Royal Bank Of Canada dropped their price target on shares of Oracle from $190.00 to $165.00 and set a “sector perform” rating for the company in a research report on Friday, September 11th. Argus reissued a “buy” rating and issued a $225.00 price objective on shares of Oracle in a research note on Monday. Morgan Stanley raised their price objective on shares of Oracle from $207.00 to $210.00 and gave the company an “equal weight” rating in a research report on Friday, September 4th. Finally, Wedbush lowered their target price on shares of Oracle from $275.00 to $240.00 and set an “outperform” rating on the stock in a research note on Thursday, June 11th. Two equities research analysts have rated the stock with a Strong Buy rating, thirty have issued a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $252.58.

Get Our Latest Research Report on ORCL

Oracle Stock Performance

NYSE:ORCL opened at $143.20 on Monday. The company has a debt-to-equity ratio of 1.89, a quick ratio of 1.12 and a current ratio of 1.17. The stock has a 50-day simple moving average of $141.12 and a two-hundred day simple moving average of $160.41. The firm has a market capitalization of $433.00 billion, a PE ratio of 22.45, a P/E/G ratio of 1.01 and a beta of 1.74. Oracle has a 52-week low of $114.50 and a 52-week high of $329.50.

Oracle (NYSE:ORCLGet Free Report) last posted its quarterly earnings data on Thursday, September 10th. The enterprise software provider reported $1.92 EPS for the quarter, topping the consensus estimate of $1.74 by $0.18. Oracle had a return on equity of 48.85% and a net margin of 26.36%.The firm had revenue of $19.34 billion for the quarter, compared to the consensus estimate of $19.13 billion. During the same quarter last year, the company earned $1.47 earnings per share. The business’s revenue for the quarter was up 29.6% compared to the same quarter last year. Oracle has set its Q2 2027 guidance at 1.850-1.930 EPS and its FY 2027 guidance at 8.100-8.100 EPS. Analysts forecast that Oracle will post 6.62 EPS for the current year.

Oracle Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 23rd. Stockholders of record on Friday, October 9th will be given a dividend of $0.50 per share. The ex-dividend date is Friday, October 9th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.4%. Oracle’s dividend payout ratio (DPR) is presently 31.35%.

Insider Activity at Oracle

In related news, Vice Chairman Jeffrey Henley sold 400,000 shares of the business’s stock in a transaction dated Wednesday, June 24th. The stock was sold at an average price of $159.16, for a total value of $63,664,000.00. Following the sale, the insider directly owned 400,000 shares in the company, valued at approximately $63,664,000. The trade was a 50.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 40.90% of the company’s stock.

Institutional Trading of Oracle

A number of large investors have recently added to or reduced their stakes in the company. Bullseye Investment Management LLC purchased a new stake in shares of Oracle during the 2nd quarter worth approximately $1,676,000. Bouchey Financial Group Ltd. purchased a new position in shares of Oracle in the second quarter valued at $229,000. Capstone Financial Advisors Inc. grew its holdings in shares of Oracle by 3.6% in the second quarter. Capstone Financial Advisors Inc. now owns 1,809 shares of the enterprise software provider’s stock valued at $265,000 after purchasing an additional 63 shares in the last quarter. Van Hulzen Asset Management LLC increased its position in Oracle by 0.7% in the second quarter. Van Hulzen Asset Management LLC now owns 11,815 shares of the enterprise software provider’s stock worth $1,731,000 after purchasing an additional 81 shares during the last quarter. Finally, MCF Advisors LLC increased its position in Oracle by 3.4% in the second quarter. MCF Advisors LLC now owns 20,411 shares of the enterprise software provider’s stock worth $2,991,000 after purchasing an additional 677 shares during the last quarter. Institutional investors own 42.44% of the company’s stock.

Oracle News Summary

Here are the key news stories impacting Oracle this week:

  • Positive Sentiment: Oracle’s latest quarterly results showed revenue of approximately $19.3 billion, record AI-related bookings and cloud infrastructure revenue growth. Its remaining performance obligation backlog of roughly $664 billion reinforces expectations for sustained demand. Top investor discusses Oracle stock
  • Positive Sentiment: Reports that OpenAI investors are considering a funding round at a valuation of roughly $1.2 trillion could ease concerns about an AI spending slowdown and potentially benefit Oracle because of its close ties to OpenAI and AI infrastructure demand. OpenAI valuation could lift Oracle
  • Positive Sentiment: Wall Street remains broadly constructive, with some analysts maintaining Buy ratings and one cited price target implying substantial upside from current levels. Oracle also introduced Java 27 with enhanced post-quantum security and AI capabilities, while Quorum Health selected Oracle across its clinical, financial and operational systems. Quorum Health selects Oracle
  • Neutral Sentiment: Oracle is reportedly conducting another round of layoffs while management emphasizes disciplined spending and simpler processes. The cuts may improve efficiency, but they also highlight the tension between cost control and the company’s aggressive AI expansion. Oracle spending and layoffs report
  • Negative Sentiment: Investors remain concerned that Oracle’s planned tens of billions of dollars in AI data-center investment will exceed internally generated cash flow. Higher borrowing costs and additional financing could pressure free cash flow, margins and valuation. Oracle financing plan risks
  • Negative Sentiment: The stock’s recent decline reflects fears that OpenAI could reduce or abandon planned commitments, alongside broader worries that AI infrastructure spending may slow. One analyst downgraded Oracle despite acknowledging strong quarterly demand, arguing that results have not yet demonstrated adequate returns on the spending spree. Oracle rating downgrade

Oracle Company Profile

(Get Free Report)

Oracle Corporation is a global enterprise technology company that develops and provides database software, cloud infrastructure, business applications and related technology services. Its offerings help organizations manage data, run applications, support business operations and build technology environments across on-premises, hybrid and cloud-based settings.

The company’s products include Oracle Database, MySQL, Java, Oracle Cloud Infrastructure and a broad portfolio of cloud applications for enterprise resource planning, financial management, human resources, supply chain management, customer experience and industry-specific operations.

Featured Articles

Analyst Recommendations for Oracle (NYSE:ORCL)

Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.